Silke B. Bodendiek

The KCa3.1 Blocker TRAM-34 Reduces Infarction and Neurological Deficit in a Rat Model of Ischemia/Reperfusion Stroke

Yi‐Je Chen, Girija Raman, Silke B. Bodendiek et al. · Journal of Cerebral Blood Flow & Metabolism · 2011 · 106 citations · Full text

Brain Infiltrating Macrophages, Cerebrovascular Disease, Rat Model +23

Pharmacological activation of KCa3.1/KCa2.3 channels produces endothelial hyperpolarization and lowers blood pressure in conscious dogs

Gorm Nielsen, Silke B. Bodendiek, Jan Bert Gramsbergen et al. · British Journal of Pharmacology · 2011 · 66 citations · Full text

4-Phenoxybutoxy-substituted heterocycles – A structure–activity relationship study of blockers of the lymphocyte potassium channel Kv1.3

Silke B. Bodendiek, Cédrick Mahieux, Wolfram Hänsel et al. · European Journal of Medicinal Chemistry · 2008 · 53 citations · Full text

Molecular Pharmacology, Biochemistry, 4-Phenoxybutoxy-substituted Heterocycles +6

Potassium Channel Block by a Tripartite Complex of Two Cationophilic Ligands and a Potassium Ion

Pavel I. Zimin, Bojan Garic, Silke B. Bodendiek et al. · Molecular Pharmacology · 2010 · 29 citations · Full text

Triarylmethanes, a New Class of Cx50 Inhibitors

Silke B. Bodendiek, Clio Rubiños, M. Pilar Trelles et al. · Frontiers in Pharmacology · 2012 · 17 citations · Full text